سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Enhancing the Rational Use of Albumin and Intra-venous Pantoprazole in Hospitals by Implementing Pharmaceutical Guidelines in Hospitals: A Quasi-experimental study

Publish Year: 1400
Type: Journal paper
Language: English
View: 142

This Paper With 8 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_PBRE-7-3_006

Index date: 30 December 2023

Enhancing the Rational Use of Albumin and Intra-venous Pantoprazole in Hospitals by Implementing Pharmaceutical Guidelines in Hospitals: A Quasi-experimental study abstract

Background: Irrational use of drugs is a serious global problem, especially in developing countries. Scientific evidence has announced albumin and intravenous pantoprazole as expensive drugs, i.e., relatively irrationally applied in hospitals without following the guidelines.  Objectives: Considering health cost management policy in Iran, this study aimed to evaluate the effects of implementing pharmaceutical guidelines to rationalize and reduce the use of albumin and intravenous pantoprazole and the related inappropriate costs. Methods: This quasi-experimental study was conducted from January 2016 to October 2018 in two teaching Hospitals in Jahrom City, Iran. Pharmaceutical guidelines were implemented throughout the physical training as well as a pharmacist-led intervention and supervising. All inpatient prescriptions of the studied medicines were evaluated.  Results: Before conducting the intervention (June 2016), an average of 357 albumin vials were monthly used; after performing the interventions, 166 and 167 vials were used in 2017 and 2018, respectively. Reduced albumin use rate equaled 48%, i.e., significant (P=0.002). Annual cost-saving was estimated to be 25000 USD. In comparison to the previous year, there were 46% and 70% reductions in the mean number of pantoprazole vials prescribed in 2017 and 2018, respectively (P=0.005). Consuming pantoprazole was measured to be 1457 vials per month in 2017 and 795 in 2018, i.e., significant (P=0.002). Cost-Saving in intravenous pantoprazole was estimated to be 16000 USD in 2017 and 25000 USD in 2018.  Conclusion: Prescription strategies, such as pharmaceutical guidelines with educational measures, pharmacist-led intervention, monitoring the prescribing drug, and feedback to prescribers can significantly decrease the inappropriate use of expensive drugs and their costs.

Enhancing the Rational Use of Albumin and Intra-venous Pantoprazole in Hospitals by Implementing Pharmaceutical Guidelines in Hospitals: A Quasi-experimental study Keywords:

Enhancing the Rational Use of Albumin and Intra-venous Pantoprazole in Hospitals by Implementing Pharmaceutical Guidelines in Hospitals: A Quasi-experimental study authors

Nader Sharifi

Research Center for Social Determinants of Health, Faculty of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran.

Vahid Kohpeima Jahromi

Research Center for Social Determinants of Health, Faculty of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran.

Rahim Raoofi

Department of Infectious Diseases, Faculty of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran.

Mohamad Rahmanian

Department of Anesthesiology, Faculty of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran.

Razieh Zahedi

Research Center for Social Determinants of Health, Faculty of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
Organization WH. Promoting rational use of medicines: core components. Geneva: ...
Khan MI, Ara N. Promoting rational prescribing among medical practitioners. ...
Okyay RA, Erdoğan A. Self-medication practices and rational drug use ...
Organization WH. Rational drug use. Report on a regional consultation, ...
Organization WH. WHO guideline on country pharmaceutical pricing policies. World ...
Kebriaeezadeh A, Koopaei NN, Abdollahiasl A, Nikfar S, Mohamadi N. ...
Ghasemi H, Raeeszadeh M. Comparison of increase in medication costs ...
Dumoulin J, Kaddar M, Velásquez G, Organization WH. Guide d’analyse ...
Barnett A, Creese AL, Ayivor ECK. The economics of pharmaceutical ...
Rafsanjani ZJ, Kamyab H, Nosrati M, Najafi S, Keshavarz-Bahaghighat H, ...
Noormandi A, Karimzadeh I, Mirjalili M, Khalili H. Clinical and ...
Jahangard-Rafsanjani Z, Javadi MR, Torkamandi H, Alahyari S, Talasaz AH, ...
Boldt J. Use of albumin: an update. Br J Anaesth. ...
Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid ...
Brecher ME, Owen HG, Bandarenko N. Alternatives to albumin: starch ...
Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, ...
World Health Organization. Achieving better health outcomes and efficiency gains ...
Lu Y, Hernandez P, Abegunde D, Edejer T. The world ...
Holloway KA. Combating inappropriate use of medicines. Expert Rev Clin ...
Talasaz AH, Jahangard-rafsanjani Z, Ziaie S, Fahimi F. Evaluation of ...
Matos GC, Rozenfeld S, Martins M. Human albumin use at ...
Haghdoost AA, Mehrolhassani MH, Khajehkazemi R, Fallah MS, Dehnavieh R. ...
Vazin A, Karimzadeh I, Karamikhah R, Oveisi Z, Mohseni S, ...
Ala S, Salehifar E, Chalaki V. Evaluation of Albumin Use ...
Kazemi Y, Hadavand N, Hayatshahi A, Torkamandi H, Gholami K, ...
Khan MI, Ara N. Promoting rational prescribing among medical practitioners. ...
Hogerzeil HV, Ross-Degnan D, Laing RO, Ofori-Adjei D, Santoso B, ...
Dastan F, Jamaati H, Emami H, Haghgoo R, Eskandari R, ...
Piovani D, Clavenna A, Sequi M, Cartabia M, Bortolotti A, ...
نمایش کامل مراجع